VC  Hopen Life Science Ventures

     Office Locations:

171 Monroe NW, Suite 410
Grand Rapids, MI 49503
Phone: 616-325-2110
Fax: 616-325-2111

Get all office locations for this firm with a National Database subscription.


  • Early
  • Expansion
  • Growth
  • Middle Market



  • Life Sciences & Healthcare
  • Medical Device



    Hopen Life Sciences was formed in 2006 to take advantage of converging market dynamics in the life science field in the region. The team consists of experienced professionals with diverse life science backgrounds in research and development, business development, operations, marketing, clinical trials, finance, and patient care. To date, Hopen has leveraged its network of life science expertise as well as financial capital to invest in a portfolio of early- to mid-stage companies that includes diagnostics, therapeutics, medical devices, and enabling technologies. Hopen seeks to invest $3 to $5 million over the life of the investment, but have the flexibility to do more or less. Hopen Fund I has invested in seven companies including one exit through a combination of initial and follow-on investments. All six of the remaining invested assets continue to progress and have raised, in combination with its syndicated partners, a total of $110 million toward continued creation of investor value. In 2010, the Hopen leadership team decided to expand its investment pool to create a new Life Science venture fund, Hopen Fund II. Through this fund, Hopen will continue to build upon our fundamental approach to investing in leading edge life science opportunities. In July 2011, Hopen announced an initial close of $25 million for its second fund. Currently, Hopen manages over $65 million between the two funds.



      Fund Name



    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Jerry Callahan PHD Venture Partner
    Mark Olesnavage Managing Director
    Michael Fulton MD Managing Director
    Michael Jandernoa Managing General Partner
    Thomas Buschert CPA Chief Financial Officer


    Portfolio companies include:

        web link

      Cirius Therapeutics
        web link

      Delphinus Medical Technologies
        web link

      Intervention Insights
        web link

      Metabolic Solutions Development
        web link

        web link

        web link

      Tolera Therapeutics
        web link

      Transcorp Medical
        web link


    Recent News: